Nostos was founded by David Gorgan, Rocio Acuna Hidalgo in 2019.

Who are Nostos's investors?

Nostos's investors include 42CAP, Acequia Capital (AceCap), Entrepreneur First, Faber, Frontline Ventures.

Where is Nostos headquartered?

Nostos is headquartered in Berlin, DE.

Nostos

Berlin, DE · Founded 2019 · 5 known investors

Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases. The company addresses the diagnostic bottleneck in genetic sequencing by providing better information interpretation for patients and healthcare systems.

AI & Machine LearningBiotechDigital HealthHealthtechin /nostosgenomics @nostosgenomics

Founders & leadership

Nostos was founded in 2019 by David Gorgan and Rocio Acuna Hidalgo.

David GorganinFounder

Rocio Acuna HidalgoinCTO

Investors · 5

42CAPBerlin · $550K – $3.3M

Acequia Capital (AceCap)Seattle · $100K – $5M

Entrepreneur FirstBengaluru · $1M – $7M

FaberLisbon · $2.7M

Frontline VenturesSan Francisco · $540K – $3.2M

Competitors · 1

by search overlap

Oup12 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.

Companies competing with Nostos for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

SNF Nostos Run 2026 - Stavros Niarchos Foundationsnf.org · Apr 2026

Nostos Genomics Raises €5M in Seed Funding Round | GenomeWebgenomeweb.com · Feb 2022

What does your genetic data tell about you? Berlin’s Nostos Genomics raises €5 million to speed up disease diagnosis - Tech.eutech.eu · Feb 2022

Nostos Genomics - $6M Seed Stage Venture | Startup Introsstartupintros.com · Feb 2022

Nostos Foundation - Nonprofit Explorer - ProPublicaprojects.propublica.org · May 2013

Nostos Genomics raised €5M in a seed round backed by 42CAP, Frontline Ventures, Amino Collective and Entrepreneur First. | Nordic 9nordic9.com

Frequently asked questions

What does Nostos do?: Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases. The company addresses the diagnostic bottleneck in genetic sequencing by providing better information interpretation for patients and healthcare systems.
Who founded Nostos?: Nostos was founded by David Gorgan, Rocio Acuna Hidalgo in 2019.
Who are Nostos's investors?: Nostos's investors include 42CAP, Acequia Capital (AceCap), Entrepreneur First, Faber, Frontline Ventures.
Where is Nostos headquartered?: Nostos is headquartered in Berlin, DE.